Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01082731Phase 4Terminated
A Phase 4 trial of artesunate + mefloquine in Plasmodium falciparum malaria, sponsored by Centers for Disease Control and Prevention. Started Nov 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01082731.